Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of older adults with colorectal cancer - The state-of-the-art in 2026.

Journal of geriatric oncology·2026
Same author

Glomeruloid haemangioma in Erdheim-Chester disease: An atypical skin manifestation associated with elevated vascular endothelial growth factor-A levels.

British journal of haematology·2026
Same author

Xanthogranulomatous Inflammatory Pelvic Mass Mimicking Malignancy: Successful Conservative Treatment and Narrative Insights into Diagnosis and Management.

Journal of clinical medicine·2026
Same author

Does neoadjuvant therapy reduce pancreatic fistula after pancreatoduodenectomy and distal pancreatectomy?-a systematic review and meta-analysis.

Hepatobiliary surgery and nutrition·2026
Same author

Spatial biomarker discovery via interpretable semantic learning in histopathology.

Cancer cell·2026
Same author

Sequential alternation of nal-IRI/5-FU and gemcitabine/nab-paclitaxel versus nal-IRI/5-FU versus gemcitabine/nab-paclitaxel in first-line metastatic pancreatic cancer: results of the randomized phase II PRODIGE 61-FUNGEMAX trial (France).

EClinicalMedicine·2026

Related Experiment Video

Updated: Jan 6, 2026

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
06:32

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

2.8K

A deep learning-based multiscale integration of spatial omics with tumor morphology.

Benoît Schmauch1, Loïc Herpin2, Antoine Olivier2

  • 1Owkin, Paris, France. benoit.schmauch@owkin.com.

Nature Communications
|November 27, 2025
PubMed
Summary

We developed MISO, a deep learning method to predict spatial transcriptomics from standard H&E slides. This approach integrates tumor morphology with gene expression, enabling spatial analysis for more cancer patients.

More Related Videos

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
11:00

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

17.8K
Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach
07:16

Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach

Published on: April 25, 2025

688

Related Experiment Videos

Last Updated: Jan 6, 2026

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
06:32

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

2.8K
Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
11:00

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

17.8K
Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach
07:16

Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach

Published on: April 25, 2025

688

Area of Science:

  • Oncology
  • Computational Biology
  • Genomics

Background:

  • Spatial transcriptomics (spTx) provides crucial insights into tumor microenvironments and therapeutic targets.
  • Current spTx technologies are not yet widely accessible for routine clinical use.
  • Hematoxylin and eosin (H&E) slides are standard in cancer diagnostics.

Purpose of the Study:

  • To develop a deep learning method for integrating spTx data with tumor morphology from H&E slides.
  • To enable prediction of spTx from routinely available H&E images.
  • To bridge the gap between advanced spTx research and clinical practice.

Main Methods:

  • A deep learning-based approach named MISO (multiscale integration of spTx with tumor morphology) was developed.
  • MISO was trained to predict spTx data using H&E stained histological images.
  • The model was validated on 72 10X Genomics Visium samples and 348 additional samples from the MOSAIC consortium.

Main Results:

  • MISO successfully predicted spTx from H&E images across multiple cancer types.
  • The method demonstrated superior performance compared to existing approaches in extensive benchmarks.
  • MISO achieved near single-cell resolution for spatially-resolved gene expression prediction.

Conclusions:

  • MISO offers a scalable solution for predicting spatial gene expression from H&E slides.
  • This approach can democratize the use of spTx data in cancer research and diagnostics.
  • MISO facilitates deeper understanding of tumor biology and identification of therapeutic targets.